HALO Clinical AI Flyer
Check out our flyer to learn more about HALO Clinical AI Solutions
HALO Clinical AI Flyer Read More »
Check out our flyer to learn more about HALO Clinical AI Solutions
HALO Clinical AI Flyer Read More »
Learn more about Lung Macrodissect AI, an AI-based tool for tumor content quantification and ROI selection guidance.
Learn more about the automated workflow and benefits of Lung Macrodissect AI.
Lung Macrodissect AI Brochure Read More »
Learn more about the development and validation of an AI-based molecular pathology algorithm for estimating tumour cells in lung adenocarcinoma.
As 2024 draws to a close, we at Indica Labs would like to thank the customers and collaborators who helped fill 2024 with exciting discoveries, events, and partnerships. It is a great honor to have played a part in customers’ contributions to scientific fields ranging from immuno-oncology to infectious disease, immunology, neuroscience, and metabolism.
Looking Back: Reviewing 2024 at Indica Labs Read More »
Albuquerque, NM, October 30, 2024 – The Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), among the leading institutes for clinical digital pathology and research in the European Union, has partnered with Indica Labs to implement digital primary diagnostics with integrated AI-powered image analysis.
Albuquerque, NM – 1 August 2024 – Indica Labs, the leading provider of AI-powered digital pathology solutions, proudly announces the launch of Lung Macrodissect AI, a groundbreaking tool that revolutionizes slide macrodissection and molecular pathology workflows.